Chemotherapy and zoledronate sensitize solid tumour cells to Vgamma9Vdelta2 T cell cytotoxicity.

Mattarollo, Stephen R

Chemotherapy and zoledronate sensitize solid tumour cells to Vgamma9Vdelta2 T cell cytotoxicity. [electronic resource] - Cancer immunology, immunotherapy : CII Aug 2007 - 1285-97 p. digital

Publication Type: Journal Article

0340-7004

10.1007/s00262-007-0279-2 doi


Adenocarcinoma--immunology
Antineoplastic Agents--pharmacology
Apoptosis--drug effects
Breast Neoplasms--immunology
Burkitt Lymphoma--immunology
Carcinoma--immunology
Cell Line, Tumor--drug effects
Cisplatin--pharmacology
Colorectal Neoplasms--immunology
Concanavalin A--pharmacology
Cytotoxicity, Immunologic--drug effects
Diphosphonates--pharmacology
Doxorubicin--pharmacology
Drug Screening Assays, Antitumor
Drug Synergism
Etoposide--pharmacology
Female
Genes, T-Cell Receptor delta
Genes, T-Cell Receptor gamma
Humans
Imidazoles--pharmacology
Interferon-gamma--biosynthesis
Lovastatin--analogs & derivatives
Lung Neoplasms--immunology
Male
Membrane Glycoproteins--analysis
Neoplasms--immunology
Perforin
Pore Forming Cytotoxic Proteins--analysis
Prostatic Neoplasms--immunology
Receptors, Antigen, T-Cell, gamma-delta--immunology
T-Lymphocyte Subsets--immunology
Urinary Bladder Neoplasms--immunology
Vincristine--pharmacology
Zoledronic Acid